chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Restlessness, Somnolence
Clinical narrative: Pressure in eyes; Pressure in  ears; soreness in complete body; sleepy; restless; bad dreams; diarrhea; This is a spontaneous report from non-contactable consumer, the patient. A 50-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) in the right arm on 22Mar2021 at 14:00 (at the age of 50-year-old), as a single dose for COVID-19 immunisation. The patients medical history included penicillin allergy, grass allergy and tetracycline. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. THE patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient did not received medication within 2 weeks of vaccination. The past drug history included codeine (CODEINE). On 22Mar2021 the patient experienced pressure in eyes and ears, soreness in complete body, sleepy, restless, bad dreams and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The therapeutic measures and treatment were not taken as a result of the events. The clinical outcomes of the events Pressure in eyes and ears, soreness in complete body, sleepy, restless, bad dreams and diarrhea were recovering at the time of report.   No follow-up attempts are possible; Information about batch cannot be obtained.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Influenza, Malaise
Clinical narrative: tiredness; headache; muscle pain; chills; fever; nausea; feeling unwell; All the flu symptoms  tiredness, headache, musclepain, chills, fever, nausea, feelingunwell; injection site pain; This is a spontaneous report received from a non-contactable consumer, the patient. A 27-years-old male patient of received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 23Mar2021 at 08:00 AM (at the age of 27-years-old) as a single dose for COVID-19 immunisation. The patient medical history was not reported. Concomitant medications was not reported. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient was not allergic to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 24Mar2021, at 02:00 AM, It was reported that the patient experienced all the flu symptoms, injection site pain, tiredness, headache, muscle pain, chills, fever, nausea, feeling unwell. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient received ibuprofen (MANUFACTURER UNKNOWN) and icepack/heated pack as a treatment measure for the reported events. The clinical outcome of flu symptoms and vaccination site pain, tiredness, headache, muscle pain, chills, fever, nausea and feeling unwell was recovering at the time of report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia, Vaccination site pain
Clinical narrative: tiredness; headache; muscle pain; chills; fever; nausea; feeling unwell; All the flu symptoms  tiredness, headache, musclepain, chills, fever, nausea, feelingunwell; injection site pain; This is a spontaneous report received from a non-contactable consumer, the patient. A 27-years-old male patient of received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 23Mar2021 at 08:00 AM (at the age of 27-years-old) as a single dose for COVID-19 immunisation. The patient medical history was not reported. Concomitant medications was not reported. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient was not allergic to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 24Mar2021, at 02:00 AM, It was reported that the patient experienced all the flu symptoms, injection site pain, tiredness, headache, muscle pain, chills, fever, nausea, feeling unwell. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient received ibuprofen (MANUFACTURER UNKNOWN) and icepack/heated pack as a treatment measure for the reported events. The clinical outcome of flu symptoms and vaccination site pain, tiredness, headache, muscle pain, chills, fever, nausea and feeling unwell was recovering at the time of report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chills, Pain, Pyrexia
Clinical narrative: Achy body; fever - 101.3; Chills; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8727) via an unspecified route of administration in the left arm on 23Mar2021 at 15:00 (at the age of 57-years-old) as a single dose for COVID-19 Immunisation. Medical history included high blood pressure. The patient did not have any allergy to medications, food or other products. The patient received prescribed medicine (unspecified) within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 6203) via an unspecified route of administration on 02Mar2021 at 17:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 at 06:00, the patient experienced fever of 101.3 (unit unspecified), chills and achy body. The patient received Tylenol as treatment for the events. The clinical outcome of the events fever 101.3, chills and achy body was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chills, Fatigue, Influenza like illness, Malaise
Clinical narrative: Achy body; fever - 101.3; Chills; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8727) via an unspecified route of administration in the left arm on 23Mar2021 at 15:00 (at the age of 57-years-old) as a single dose for COVID-19 Immunisation. Medical history included high blood pressure. The patient did not have any allergy to medications, food or other products. The patient received prescribed medicine (unspecified) within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 6203) via an unspecified route of administration on 02Mar2021 at 17:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 at 06:00, the patient experienced fever of 101.3 (unit unspecified), chills and achy body. The patient received Tylenol as treatment for the events. The clinical outcome of the events fever 101.3, chills and achy body was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Nausea, Pain, Pyrexia
Clinical narrative: Achy body; fever - 101.3; Chills; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8727) via an unspecified route of administration in the left arm on 23Mar2021 at 15:00 (at the age of 57-years-old) as a single dose for COVID-19 Immunisation. Medical history included high blood pressure. The patient did not have any allergy to medications, food or other products. The patient received prescribed medicine (unspecified) within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 6203) via an unspecified route of administration on 02Mar2021 at 17:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 at 06:00, the patient experienced fever of 101.3 (unit unspecified), chills and achy body. The patient received Tylenol as treatment for the events. The clinical outcome of the events fever 101.3, chills and achy body was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Pain in extremity, Pyrexia
Clinical narrative: Low grade fever; Nausea; Soreness in arm; Severe headache; Fatigue; This is a spontaneous report received from a non-contactable consumer, the patient. A 42-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration in the left arm on 02Mar2021 at 10:45 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration in the left arm on 23Mar2021 at 10:45 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant past medical history. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient did not have any allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021, the patient experienced low grade fever, nausea, soreness in arm, severe headache and fatigue. The adverse event did not result in doctor or other healthcare professional office or clinic visit or emergency room visit. The patient did not receive any treatment for the events. The clinical outcome of the events low grade fever, nausea, soreness in arm, severe headache and fatigue were resolving at the time of this report .   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Nausea, Pyrexia
Clinical narrative: Fever of 101.6; chills; Headache; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 41-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 23Mar2021 at 13:30 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EL3248) via an unspecified route of administration in the left arm on 03Mar2021 (at the age of 41-years-old), as a single dose for Covid-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On 24Mar2021 at 02:00, the patient experienced fever of 101.6, chills, headache and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient underwent body temperature and results was 101.6 (Unknown units). The patient did not received treatment for the reported events. The clinical outcome of the events fever, chills, headache and nausea were recovering at the time of this report.     No follow-up attempts are needed. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness postural, Headache, Vertigo
Clinical narrative: Dizziness when sitting up; Head spinning dizziness; Headache; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8730) via an unspecified route of administration in the left arm on 23Mar2021 at 16:30 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis (as reported RA), crohn's, breast cancer, lymphoma (brought on by chemo), overweight, heart disease. The patient had allergy to latex. The patient received unspecified medications within 2 weeks of COVID vaccine. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021, the patient experienced dizziness when sitting up, head spinning dizziness and headache. Rode it out and was able to stand eventually. Events started in the evening of the shot and into second day. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of postural dizziness, vertigo and headache was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Vaccination site pain
Clinical narrative: soreness at the injection site.; This is a spontaneous report from a non-contactable consumer. A patient of an unknown age and gender received an unknown dose of BNT162b2 (PFIZER- BIONTECH COVID-19 mRNA VACCINE, Lot number: EL3247) via an unspecified route of administration on 23Mar2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On an unknown date in Mar2021, the patient experienced soreness at the injection site. The clinical outcome of the event soreness at the injection site was unknown at the time of this report. No follow up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: soreness at the injection site.; This is a spontaneous report from a non-contactable consumer. A patient of an unknown age and gender received an unknown dose of BNT162b2 (PFIZER- BIONTECH COVID-19 mRNA VACCINE, Lot number: EL3247) via an unspecified route of administration on 23Mar2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On an unknown date in Mar2021, the patient experienced soreness at the injection site. The clinical outcome of the event soreness at the injection site was unknown at the time of this report. No follow up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Pain in extremity, Panic attack
Clinical narrative: Left arm started to heat up like fire up hot sunburn hot to neck and right arm; Panic attack; Arm a bit sore; This is a spontaneous report received from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route administration in the left arm on 24Mar2021 at 12:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included leukaemia (childhood in remission). The patient had no known allergies. Concomitant mediation included norethindrone; ethinyl estradiol (MICROGESTIN), esomeprazole (MANUFACTURER UNKNOWN), omega3 (MANUFACTURER UNKNOWN) and turmeric all drugs started on an unknown date for unknown indications. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. On 24Mar2021 at 12:00 (minutes after the injection), the patient's whole left arm started to heat up like fire up hot, sunburn hot. No spots no rashes were present, it continued to travel over neck to right arm which was not as severe, but also not amazing. After about 10 minutes and a panic attack later it was gone. The patient felt completely fine but reported to have had a sore arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events experienced. The clinical outcome of the events left arm started to heat up like fire up hot sunburn hot to neck and right arm and panic attack was resolved on 24Mar2021. The clinical outcome of the event arm a bit sore was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Night sweats
Clinical narrative: Chills; Fever; Night Sweats; Headache; Muscle Aches; Exhaustion; This is a spontaneous report from a non contactable consumer, the patient. A 45-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6207) via an unspecified route of administration in the left arm on 18March2021 at 14:30 (at the age of 45-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient was allergic to penicillin. The patient had not received any other vaccines within four weeks prior to the vaccination. It was unknown whether prior to vaccination, patient was diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 19March2021 at 15:00, the patient experienced chills, fever, night sweats, headache, muscle aches and exhaustion. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcome of the events chills, fever, night sweats, headache, muscle aches, exhaustion was recovered on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Chills; Fever; Night Sweats; Headache; Muscle Aches; Exhaustion; This is a spontaneous report from a non contactable consumer, the patient. A 45-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6207) via an unspecified route of administration in the left arm on 18March2021 at 14:30 (at the age of 45-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient was allergic to penicillin. The patient had not received any other vaccines within four weeks prior to the vaccination. It was unknown whether prior to vaccination, patient was diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 19March2021 at 15:00, the patient experienced chills, fever, night sweats, headache, muscle aches and exhaustion. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcome of the events chills, fever, night sweats, headache, muscle aches, exhaustion was recovered on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Somnolence
Clinical narrative: Sleepy; Tired; Shoulder pain; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 24Mar2021 at 10:00 (at the age of 33-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 24Mar2021, the patient experienced sleepy, tired and shoulder pain. The patient did not receive any treatment for events. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The clinical outcome of the events sleepy, tiredness and shoulder pain was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Hyperhidrosis, Nausea, Pain in extremity
Clinical narrative: Nausea; Vomiting; Diarrhea; Chills; Sweats; Severe pain in left arm; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER COVID-19 mRNA VACCINE BIONTECH, Lot number: ep6955), via an unspecified route of administration in the left arm on 23Mar2021 at 11:00 (at the age of 27-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included ethinyl estradiol; norgestimate (TRI-PREVIFEM) for an unspecified indication from unknown dates. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 23Mar2021 at 20:00, the patient experienced nausea, vomiting, diarrhoea, chills, sweats and severe pain in left arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. The patient did not receive any treatment for the reported events. The clinical outcome of the events nausea, vomiting, diarrhoea, chills, sweats, and severe pain in left arm were unknown.  No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Nausea; Vomiting; Diarrhea; Chills; Sweats; Severe pain in left arm; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER COVID-19 mRNA VACCINE BIONTECH, Lot number: ep6955), via an unspecified route of administration in the left arm on 23Mar2021 at 11:00 (at the age of 27-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included ethinyl estradiol; norgestimate (TRI-PREVIFEM) for an unspecified indication from unknown dates. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 23Mar2021 at 20:00, the patient experienced nausea, vomiting, diarrhoea, chills, sweats and severe pain in left arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. The patient did not receive any treatment for the reported events. The clinical outcome of the events nausea, vomiting, diarrhoea, chills, sweats, and severe pain in left arm were unknown.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Cough, Dyspnoea, Ear pain
Clinical narrative: congestion intermittently through the night; Headcahe; Earache; Nausea; Lymph node pain; General body pain; Pain from injection site; Joint pain /pain radiating to elbow; Chills; Fever; Cough; hard time breathing; This is a spontaneous report received from a contactable consumer, the patient . A 42-year-old female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration in an unspecified arm on 22Mar2021 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patients medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19 and has not been tested for COVID-19 since the vaccination. On 22Mar2021, the patient experienced pain from injection site (vaccination site pain) which radiated to elbow, chills and fever, cough developed, hard time breathing (breathing difficulty), congestion intermittently through the night (nasal congestion) headache developed, ear ache developed, nausea, pain in lymph nodes (lymph node pain), body aches (general body pain) and join pain especially along the back (joint pain). No treatment was received for the adverse events. The clinical outcome of the events vaccination site pain, chills, fever, cough, breathing difficulty, headache, ear ache, nausea, nasal congestion lymph node pain, general body pain and joint pain was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymph node pain, Nasal congestion, Nausea, Pain
Clinical narrative: congestion intermittently through the night; Headcahe; Earache; Nausea; Lymph node pain; General body pain; Pain from injection site; Joint pain /pain radiating to elbow; Chills; Fever; Cough; hard time breathing; This is a spontaneous report received from a contactable consumer, the patient . A 42-year-old female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration in an unspecified arm on 22Mar2021 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patients medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19 and has not been tested for COVID-19 since the vaccination. On 22Mar2021, the patient experienced pain from injection site (vaccination site pain) which radiated to elbow, chills and fever, cough developed, hard time breathing (breathing difficulty), congestion intermittently through the night (nasal congestion) headache developed, ear ache developed, nausea, pain in lymph nodes (lymph node pain), body aches (general body pain) and join pain especially along the back (joint pain). No treatment was received for the adverse events. The clinical outcome of the events vaccination site pain, chills, fever, cough, breathing difficulty, headache, ear ache, nausea, nasal congestion lymph node pain, general body pain and joint pain was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: congestion intermittently through the night; Headcahe; Earache; Nausea; Lymph node pain; General body pain; Pain from injection site; Joint pain /pain radiating to elbow; Chills; Fever; Cough; hard time breathing; This is a spontaneous report received from a contactable consumer, the patient . A 42-year-old female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration in an unspecified arm on 22Mar2021 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patients medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19 and has not been tested for COVID-19 since the vaccination. On 22Mar2021, the patient experienced pain from injection site (vaccination site pain) which radiated to elbow, chills and fever, cough developed, hard time breathing (breathing difficulty), congestion intermittently through the night (nasal congestion) headache developed, ear ache developed, nausea, pain in lymph nodes (lymph node pain), body aches (general body pain) and join pain especially along the back (joint pain). No treatment was received for the adverse events. The clinical outcome of the events vaccination site pain, chills, fever, cough, breathing difficulty, headache, ear ache, nausea, nasal congestion lymph node pain, general body pain and joint pain was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain
Clinical narrative: Pain from lymph node under the arm where the shot was given.; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6207) via an unspecified route of administration in the left arm on 22Mar2021 at 18:15 (at the age of 68-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known sulfa allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 01Mar2021 at 14:00 (at the age of 68-years-old), as a single dose for COVID-19 immunisation. The patient received unspecified antibiotic within two weeks of vaccination. On 24Mar2021 at 07:00, the patient experienced pain from lymph node under the arm where the shot was given. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the reported event. The clinical outcome of the event pain from lymph node under the arm was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pain, Pyrexia
Clinical narrative: Soreness at injection site.; Chills over night; body aches; headache; fever; This is a spontaneous report received from a contactable consumer, the patient. A 35-year-old adult male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: 3248), via an unspecified route of administration in the left arm on 23Mar2021 at 13:45 (at the age of 35-year-old), as a single dose for COVID-19 immunisation. The patient had no medical history and no allergies to medications, food or other products (reportedly none that patient knew of). The patient had not received any other medications within 2 weeks of vaccination nor received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3248) via an unspecified route of administration in the left arm on 02March2021 at 11:00(at the age of 35-year-old), as a single dose for COVID-19 immunisation.  The patient had not tested positive for COVID-19 since having the vaccine. The patient was not tested with COVID-19 prior to vaccination. On 24Mar2021 at 14:00, the patient experienced soreness at injection site, chills overnight, body aches, headache and 101 degree fever. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of adverse events. The clinical outcome of vaccination site pain, chills, general body pain, headache and fever was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness at injection site.; Chills over night; body aches; headache; fever; This is a spontaneous report received from a contactable consumer, the patient. A 35-year-old adult male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: 3248), via an unspecified route of administration in the left arm on 23Mar2021 at 13:45 (at the age of 35-year-old), as a single dose for COVID-19 immunisation. The patient had no medical history and no allergies to medications, food or other products (reportedly none that patient knew of). The patient had not received any other medications within 2 weeks of vaccination nor received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3248) via an unspecified route of administration in the left arm on 02March2021 at 11:00(at the age of 35-year-old), as a single dose for COVID-19 immunisation.  The patient had not tested positive for COVID-19 since having the vaccine. The patient was not tested with COVID-19 prior to vaccination. On 24Mar2021 at 14:00, the patient experienced soreness at injection site, chills overnight, body aches, headache and 101 degree fever. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of adverse events. The clinical outcome of vaccination site pain, chills, general body pain, headache and fever was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache
Clinical narrative: Chills; Fatigue; Headaches; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Ep6955), via an unspecified route in the left arm on 23Mar2021 at 13:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included sickle cell anemia. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 24Mar2021 at 07:00, the patient experienced chills, fatigue and headaches. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown if the patient received any treatment for the events chills, fatigue and headaches. The clinical outcomes of the events chills, fatigue and headaches was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Oropharyngeal pain, Pyrexia
Clinical narrative: actually got covid in between the 1st and the 2nd dose; sore throat; had a fever; he lost his taste and smell; he lost his taste and smell; This is a spontaneous report from a contactable consumer or other non hcp (patient).  The 19-year-old male patient received first dose of BNT162B2 (Formulation: Solution for injection, Batch/Lot number: EN6207 Expiration Date: unknown), via an unspecified route of administration, administered in Arm Left on 14Mar2021 10:00 (Age at vaccination 19 years) as DOSE 1, SINGLE for covid-19 immunization. The patient had no medical history, no relevant family medical history and was not on concomitant medications. He started experiencing symptoms on 19Mar2021, which was 10 days prior to this report. It was stated his symptoms were sore throat, had a fever at some point that went away and the worst symptom was that he lost his taste and smell. On 24Mar2021, the patient was diagnosed with Covid, it was stated that actually got Covid in between the first and the second dose. The patient underwent laboratory tests and procedures on 23Mar2021 which included SARS-COV-2 TEST: result was found positive on 24Mar2021. He received no treatment for events. No additional vaccines were administered on Same date of the Pfizer Suspect. The patient did not visit to emergency room. He did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was stated the only symptom left that he had was that the taste and smell were present but the other symptoms were gone and he knew it would take a while for taste and smell to come back. Description of complaint: He has not yet had the second dose of the Pfizer Vaccine but it was scheduled for 10Apr2021. It was stated that his second dose of the Pfizer Vaccine was scheduled for next Sunday but he pushed the appointment back to 10Apr2021 and stated this was still in the 28 day window to have the second dose. It was stated that he was out of quarantine on the day of this report and had no fever and had nothing and was all healed. He had no treatment for the reported event. The events of sore throat, fever, was resolved on an unknown date in 2021. The outcome of event actually got COVID in between the first and the second dose was unknown; however, the outcome of the events of lost his taste and smell was reported as not resolved.  His patient card had no expiry date or NDC to provide.   No follow up attempts were possible. No further information was expected.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: actually got covid in between the 1st and the 2nd dose; sore throat; had a fever; he lost his taste and smell; he lost his taste and smell; This is a spontaneous report from a contactable consumer or other non hcp (patient).  The 19-year-old male patient received first dose of BNT162B2 (Formulation: Solution for injection, Batch/Lot number: EN6207 Expiration Date: unknown), via an unspecified route of administration, administered in Arm Left on 14Mar2021 10:00 (Age at vaccination 19 years) as DOSE 1, SINGLE for covid-19 immunization. The patient had no medical history, no relevant family medical history and was not on concomitant medications. He started experiencing symptoms on 19Mar2021, which was 10 days prior to this report. It was stated his symptoms were sore throat, had a fever at some point that went away and the worst symptom was that he lost his taste and smell. On 24Mar2021, the patient was diagnosed with Covid, it was stated that actually got Covid in between the first and the second dose. The patient underwent laboratory tests and procedures on 23Mar2021 which included SARS-COV-2 TEST: result was found positive on 24Mar2021. He received no treatment for events. No additional vaccines were administered on Same date of the Pfizer Suspect. The patient did not visit to emergency room. He did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was stated the only symptom left that he had was that the taste and smell were present but the other symptoms were gone and he knew it would take a while for taste and smell to come back. Description of complaint: He has not yet had the second dose of the Pfizer Vaccine but it was scheduled for 10Apr2021. It was stated that his second dose of the Pfizer Vaccine was scheduled for next Sunday but he pushed the appointment back to 10Apr2021 and stated this was still in the 28 day window to have the second dose. It was stated that he was out of quarantine on the day of this report and had no fever and had nothing and was all healed. He had no treatment for the reported event. The events of sore throat, fever, was resolved on an unknown date in 2021. The outcome of event actually got COVID in between the first and the second dose was unknown; however, the outcome of the events of lost his taste and smell was reported as not resolved.  His patient card had no expiry date or NDC to provide.   No follow up attempts were possible. No further information was expected.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: I got COVID-19; This is a spontaneous report received from a contactable consumer. A 62 (Unit: Unknown) female patient received first dose of BNT162B2((PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot/batch number not provided), via an unspecified route of administration on 15Feb2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had a first Pfizer COVID Vaccine in 15Feb2021 and Weeks later got COVID-19. The patient had an infusion of monoclonal antibodies 26Feb2021. The patient was told that she had to wait 90 days from the monoclonal antibody infusion to receive the second dose of the vaccine and it is scheduled for 31May2021 (110 days). The outcome of the event was unknown.  No follow up attempts are possible. Information about Lot/Batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: diagnosed with COVID-19 infection 9 days after she received her first dose; This is a spontaneous report from a non-contactable consumer (patient) via medical information team. A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was diagnosed with covid-19 infection 9 days after she received her first dose and 11 days after that she felt fine, and her physician informed her that she was out of the quarantine. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on an unspecified date. Patient enquired whether she should be administered with the second dose of the Pfizer's COVID-19 vaccine. The outcome of the event was recovering.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Eczema, Eye swelling, Rash, Rash pustular, Skin lesion
Clinical narrative: I have Eczema and on occasion will get a flare up lasting a few days / I have NEVER had a flare up as bad as this; break out with a rash, and pustules on my hands. This then spread to my legs, back, and swelling to my right eye; break out with a rash, and pustules on my hands. This then spread to my legs, back, and swelling to my right eye; swelling to my right eye; Both hands are loaded with bumps as well as both arms; This is a spontaneous report from a contactable consumer (patient) reported for himself. A 66-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6202), via an unspecified route of administration, administered in Arm Left on 03Mar2021 10:30 (at the age of 66 years) as DOSE 1, SINGLE for covid-19 immunisation. Facility where the most recent COVID-19 vaccine was administered was reported as other. Medical history included eczema from an unknown date. The patient was not allergies to medications, food, or other products. Concomitant medications were not reported. The patient was not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient having eczema and on occasion will get a flare up lasting a few days. However, the day after the patient received vaccine, on 04Mar2021, patient started to break out with a rash, and pustules on patient hands. This then spread to legs, back, and swelling to right eye. The patient has never had a flare up as bad as this and used usual routine to control the flare up and it was calming down some until patient received second vaccine on 24Mar2021 at the same location. The patient arms now look like the patient was an IV drug user and the rash on patient back was getting larger. On an unknown date in 2021, both hands are loaded with bumps as well as both arms. The patient has an appointment with a dermatologist on 07Apr2021. The patient was not received treatment for the adverse events. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Outcome of the events rash and rash pustular was not recovered and other events were unknown.   Additional information has been requested and will be provided as it becomes available.
Sex: M
Vaccine: COVID19
Symptoms: Anosmia, COVID-19, Malaise, SARS-CoV-2 test positive
Clinical narrative: he was not feeling well; he got COVID-19 surprisingly right after he got his first dose of the vaccine/tested positive with a PCR test; Loss of smell; This is a spontaneous report from a contactable consumer (patient). A 64-years-old male patient received first dose of bnt162b2 (PFIZER COVID 19 VACCINE, solution for injection, Batch/Lot Number: EP7534, Expiration Date: unknown), via intramuscular in left arm on 22Mar2021 as single dose for covid-19 immunization. The patient medical history included BPH from Jul2019 to unknown, Epstein-Barr (this was confirmed when he was 13-14 years old) and bladder stones from 2019 to unknown, he had typical allergies such as animal dander, mold, and mildew (Allergy multiple), allergic to Penicillin ( so they had taken him off Penicillin). The patient's historical vaccine included unspecified shingles shot in 2020 (first dose) for immunisation. The patient's concomitant medications were not reported. After he got his first dose of the vaccine, it had been about 10 days, then he was tested positive with a PCR test on night of 30Mar2021 actually 8 days after vaccine. Patient said he got the COVID test because he lost sense of smell on the 30Apr2021, which surprised him, after he was not feeling well, so he got the test. He said he was out of town, and was surprised it was positive. Patient said that he had been infused, he got a pheromone infusion called Bamlan IVI NAB on 30Mar at 07:30 one dose infused over some time, which was monoclonal antibodies as therapeutic measures of covid-19 at hospital, patient further mentioned if you ask for it they give it to you if you have rapid onset of COVID-19 you can ask for and get it. He said he asked for Remdesivir, but to get that would have been a huge process and done in hospital only over a few days. The outcome of the events was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Blood count, Blood count abnormal
Clinical narrative: low blood count; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient)  A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 17Mar2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  Medical history included cancer from 2020 to (she received 12 infusions and then was fine). Concomitant medication included prednisone.  The patient experienced low blood count on an unspecified date. The outcome was unknown.  Caller would like to know whether she should still get the 2nd dose of the Pfizer COVID vaccine as she has had a low blood count since the 1st dose. Being on prednisone, caller doesn't know if that will be a problem to getting her 2nd dose of the COVID vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.